Entry Point Capital, LLC Rx Sight, Inc. Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RXST
# of Institutions
229Shares Held
31.7MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$188 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$102 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$88.2 Million0.34% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.33MShares$67.8 Million0.13% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.41B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...